Results 161 to 170 of about 3,043 (176)
Some of the next articles are maybe not open access.
Venglustat in GBA1-related Parkinson's disease – Authors' reply
The Lancet NeurologyS Pablo Sardi +13 more
openaire +2 more sources
The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice
Brain, 2017Anna Migdalska-Richards +2 more
exaly
This thesis investigates the GBA1 gene, which encodes Glucocerebrosidase (GCase), a lysosomal enzyme critical for glucosylceramide and cholesterol metabolism. Over 300 pathogenic mutations have been identified, including L444P and N370S, which, in homozygous or compound heterozygous forms, cause Gaucher disease.
openaire +1 more source
openaire +1 more source
GBA1 deficiency negatively affects physiological α-synuclein tetramers and related multimers
Proceedings of the National Academy of Sciences of the United States of America, 2018Sangjune Kim +2 more
exaly
Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson's Disease
Movement DisordersSophia R L Vieira +2 more
exaly
The importance of astrocytes in the pathophysiology of GBA1-associated Parkinson disease
Molecular Genetics and Metabolism, 2018Benjamin McMahon +2 more
openaire +1 more source
Classification and Genotype–Phenotype Relationships of GBA1 Variants: MDSGene Systematic Review
Movement DisordersSusen Schaake +2 more
exaly

